LEAH ONOJA: Open Payments
NPI 1194252189 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $243 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
Products named: INGREZZA, Auvelity, TRINTELLIX, VRAYLAR, CAPLYTA, REXULTI.
Industry payments across TX — which companies pay providers there.
